Oncologic Therapies

Oncologic therapies

The amount of new biomedical literature that the world gets bombarded with these days may sometimes seem overwhelming. Yet, research results need to be reported in peer-reviewed journals and researchers need to publish regularly. Journal publication, whether on paper or on-line, is here to stay. However, it is not just the formal end-point of a research project; it is an integral part of resear...

2015 Review of Newly Approved Oncologic Therapies

Antioxidants in cancer therapy; their actions and interactions with oncologic therapies.

There is a concern that antioxidants might reduce oxidizing free radicals created by radiotherapy and some forms of chemotherapy, and thereby decrease the effectiveness of the therapy. The question has arisen whether concurrent administration of oral antioxidants is contraindicated during cancer therapeutics. Evidence reviewed here demonstrates exogenous antioxidants alone produce beneficial ef...

Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review

Novel targeted anti-cancer therapies have resulted in improvement in patient survival compared to standard chemotherapy. Renal toxicities of targeted agents are increasingly being recognized. The incidence, severity, and pattern of renal toxicities may vary according to the respective target of the drug. Here we review the adverse renal effects associated with a selection of currently approved ...

Chest CT for suspected pulmonary complications of oncologic therapies: how I review and report.

In cancer patient during or following oncologic therapies with respiratory symptoms and pulmonary pathology at chest CT the differential diagnosis includes infection, therapy-induced disease and tumour progression.Although CT morphology may be typical or even pathognomonic in some conditions the diagnosis is usually made by a synopsis of imaging, clinical and laboratory features.Close communica...